Curanex Pharmaceuticals shares surge 10.97% premarket after completing $15M IPO and exercising over-allotment for $2.25M.

Curanex Pharmaceuticals (CURX) surged 10.97% in premarket trading following the full exercise of its over-allotment option by underwriters, raising an additional $2.25 million. The company completed its initial public offering (IPO) on August 27, 2025, securing $15 million at $4 per share. The recent exercise of the greenshoe provision, announced September 12, 2025, indicates strong post-IPO demand and underwriter confidence, as the additional shares are typically used to stabilize or bolster the stock price. This move reinforces Curanex’s capital position and operational flexibility, likely driving investor optimism ahead of the stock’s market open.